June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
The Glaucoma Treatment Compliance Assessment Tool (GTCAT) has an organizational structure consistent with the Health Belief Model
Author Affiliations & Notes
  • Gordon Barker
    Devers Eye Institute, Portland, OR
  • Paul Cook
    University of Colorado, Aurora, CO
  • Malik Kahook
    University of Colorado, Aurora, CO
  • Jeffrey Kammer
    Vanderbilt University, Nashville, TN
  • Steven Mansberger
    Devers Eye Institute, Portland, OR
  • Footnotes
    Commercial Relationships Gordon Barker, None; Paul Cook, Merck & Co. (F), University of Colorado Hospital (F), The Children's Hospital Denver (F), National Hemophilia Association (F), University of Texas San Antonio (F); Malik Kahook, Alcon (C), Allergan (C), Merck (C), B&L (C), Glaukos (C), Ivantis (C), ClarVista Medical (P), Dose Medical (P), AMO (P), Genentech (F), Regeneron (F); Jeffrey Kammer, Allergan (C), Merck (F); Steven Mansberger, Merck (R), Alcon (C), Allergan (C), Allergan (F), Merck (F), Santen (C), Glaukos (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3522. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gordon Barker, Paul Cook, Malik Kahook, Jeffrey Kammer, Steven Mansberger; The Glaucoma Treatment Compliance Assessment Tool (GTCAT) has an organizational structure consistent with the Health Belief Model. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3522. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To determine the construct validity of the Glaucoma Treatment Compliance Assessment Tool (GTCAT) towards the organizational structure of the Health Belief Model (HBM).

Methods: We used the constructs of the HBM to create the 47-item GTCAT with a 5-point Likert scale. We determined construct validity using Principal Components Analysis (PCA) with an orthogonal rotation and a > .50 cutoff for item loading into components. We used Cronbach’s alpha (α) to evaluate the internal consistency reliability of the components. GTCAT questions with floor and ceiling effects (> 90% of responses 1 or 5 on the Likert Scale) were determined using frequency analysis.

Results: We included 184 open angle glaucoma or ocular hypertension patients on ocular hypotensive monotherapy from 3 tertiary glaucoma practices. PCA loaded 26 questions into 10 components, as determined by eigenvalues (> 1.0) and a screen plot. Six of these components were consistent with the HBM constructs of Severity, Benefits, Self-Efficacy (Medication), Self-Efficacy (Control), Barriers, and Knowledge. Another component also appeared to directly assess health behavior (Behavior). The other components were undefined as part of the HBM organizing structure. The internal consistency reliability was acceptable (α ≥ 0.70) for 6 components (Knowledge, Benefits, Self-Efficacy [Medication], Self-Efficacy [Control], Barriers, and Behavior). Severity showed borderline reliability (α = 0.67) and the remaining three undefined components showed poor reliability (α ≤ 0.30). No questions had floor or ceiling effects.

Conclusions: The GTCAT showed good construct validity and internal consistency, though it may be unnecessarily long. Further evaluations will assess the performance of a shorter question, and the predictive validity towards glaucoma medication adherence.

Keywords: 459 clinical (human) or epidemiologic studies: biostatistics/epidemiology methodology • 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.